Aspofoli 81 Tablet contains Aspirin 81mg, a low-dose antiplatelet formulation specifically designed for long-term cardiovascular protection. It helps inhibit platelet aggregation, thereby reducing the risk of heart attack, stroke, and other clot-related complications. Its daily low-dose administration ensures effective preventive care for high-risk patients.
The 81mg strength is ideal for patients requiring continuous heart health management with minimal risk of side effects. It is frequently recommended for post-surgical cardiac care, coronary artery disease management, and for individuals with elevated cardiovascular risk factors. Its reliability and safety profile make it a trusted choice among healthcare professionals.
For distributors and suppliers, Aspofoli 81 Tablet is a fast-moving, essential cardiovascular product. Hospitals, clinics, and pharmacies maintain a consistent stock due to its long-term use and regular prescriptions, providing steady repeat orders and business stability.
Including Aspofoli 81 Tablet in your product portfolio strengthens your cardiovascular segment and unlocks opportunities for bulk supply, institutional orders, export, and third-party manufacturing partnerships. Its strong market demand, essential therapy status, and dependable performance make it a highly profitable addition for any distributor or stockist.